GREATER CHINA
Introduction of Original Grant Patent (OGP) System in Hong Kong
The Hong Kong Intellectual Property Department (“HKIPD”) made major reforms to the patent system in Hong Kong in December 2019, with the introduction of the original grant patent (“OGP”) system. The OGP...
The Hong Kong Intellectual Property Department (“HKIPD”) made major reforms to the patent system in Hong Kong in December 2019, with...
Read More
SOUTHEAST ASIA
Singapore: maintaining top position in Asia for IP rights protection
In recognition of its robust Intellectual Property (IP) rights protection, Singapore ranks top again in Asia in the 2019 edition of the International Property Rights Index (IPRI). Globally, Singapore moved...
In recognition of its robust Intellectual Property (IP) rights protection, Singapore ranks top again in Asia in the 2019...
Read More
GREATER CHINA
China update: IP section in the China-US trade deal (phase one)
On 15th January 2020, the Governments of the United States of America and the People’s Republic of China signed the phase one documentation of a new Economic and Trade...
On 15th January 2020, the Governments of the United States of America and the People’s Republic of China signed...
Read More
SOUTHEAST ASIA
Indonesia – Extension of time for payment of outstanding patent annuities
In our previous news alerts dated 13th February 2019 and 28th September 2018 on non-payment of outstanding patent annuities in Indonesia, we reported that the Indonesia Directorate General of...
In our previous news alerts dated 13th February 2019 and 28th September 2018 on non-payment of outstanding patent annuities...
Read More
AUSTRALASIA
Invention ownership and patents: the importance of written agreements
Patent rights for an invention can be challenged if ownership is not 'rock-solid'. Written agreements play an important role in determining ownership and patent rights to an invention, and use of the...
Patent rights for an invention can be challenged if ownership is not 'rock-solid'. Written agreements play an important role in determining...
Read More
AUSTRALASIA
Australian Designs Checklist
We provide a checklist below covering some important aspects to consider in relation to Australian Designs. Are you seeking protection for features or appearance of a product? Generally speaking, a design registration...
We provide a checklist below covering some important aspects to consider in relation to Australian Designs. Are you seeking protection for...
Read More
SOUTHEAST ASIA
Malaysia’s new Trademarks Act 2019 – a new dawn arises
Following our recent article Malaysia’s New Trademarks Act 2019 (“new Act”) we are pleased to update that the very much anticipated new Act has now come into force following...
Following our recent article Malaysia’s New Trademarks Act 2019 (“new Act”) we are pleased to update that the very...
Read More
GREATER CHINA
China update: changes in Guidelines for Examination related to inventions in the fields of artificial intelligence (AI), internet +, big data and block chain
On 31 December, 2019 a new amendment to the Guidelines for Examination of the Chinese National Intellectual Property Administration (CNIPA) was announced. The new guidelines, which come into effect on February...
On 31 December, 2019 a new amendment to the Guidelines for Examination of the Chinese National Intellectual Property Administration (CNIPA) was...
Read More
SOUTHEAST ASIA
Singapore maintains top position in Asia for IP rights protection: International Property Rights Index 2019
In recognition of its robust Intellectual Property (IP) rights protection, Singapore ranks top again in Asia in the 2019 edition of the International Property Rights Index (IPRI). Globally, Singapore moved up one notch...
In recognition of its robust Intellectual Property (IP) rights protection, Singapore ranks top again in Asia in the 2019 edition of...
Read More
AUSTRALASIA
Biosimilars in Australia
A ‘biosimilar medicine’ or ‘biosimilar’ is a highly similar, but not identical, version of an original biological medicine (‘reference medicine’) – a medicine comprised of large complex molecules derived...
A ‘biosimilar medicine’ or ‘biosimilar’ is a highly similar, but not identical, version of an original biological medicine (‘reference...
Read More

Find Your Expert

Experts

Contact Us

Enquiries

Receive Insights

Subscribe